ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,513Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 1006

$2.47M Total Retail Price of All Prescriptions

Rank: 5 out of 1006

748 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 748 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 748 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 20,410 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
WARFARIN SODIUM 1,297 956 1 8
SIMVASTATIN 1,252 801 2 1
LEVOTHYROXINE SODIUM 954 670 3 2
LISINOPRIL 889 570 4 3
AMLODIPINE BESYLATE 847 578 5 4
METOPROLOL TARTRATE 822 610 6 7
RISPERIDONE 764 401 7 40
FUROSEMIDE 733 533 8 6
TRAZODONE HCL 636 389 9 21
OMEPRAZOLE 628 397 10 9
CLOZAPINE 616 172 11 107
DIVALPROEX SODIUM 606 233 12 53
BENZTROPINE MESYLATE 592 220 R 13 106
QUETIAPINE FUMARATE 550 249 14 45
LANTUS 486 274 15 43
METFORMIN HCL 474 268 16 10
ATORVASTATIN CALCIUM 441 337 17 5
DONEPEZIL HCL 366 320 18 17
MIRTAZAPINE 356 261 19 26
OLANZAPINE 352 190 20 68
ESCITALOPRAM OXALATE 345 278 21 27
HYDROCHLOROTHIAZIDE 344 271 22 11
ABILIFY 343 164 23 102
HALOPERIDOL 326 119 24 129
GABAPENTIN 315 182 25 20
SERTRALINE HCL 312 211 26 19
CITALOPRAM HBR 276 146 27 24
TRAMADOL HCL 269 216 28 35
METOPROLOL SUCCINATE 256 182 29 12
CARVEDILOL 255 166 30 36
LITHIUM CARBONATE 250 67 31 187
TAMSULOSIN HCL 246 191 32 23
VENLAFAXINE HCL ER 245 186 33 105
ATENOLOL 235 169 34 13
NOVOLOG 235 132 34 94
NAMENDA 231 202 36 34
POTASSIUM CHLORIDE 230 166 37 30
LEVETIRACETAM 226 100 38 72
IPRATROPIUM-ALBUTEROL 226 176 38 73
PAROXETINE HCL 222 140 40 62
BACLOFEN 215 95 41 95
SPIRIVA 214 127 42 48
SEROQUEL 208 99 43 97
PERPHENAZINE 196 75 44 211
CYMBALTA 182 110 45 41
DIVALPROEX SODIUM ER 179 60 46 127
KLOR-CON M20 175 131 47 70
PREDNISONE 170 111 48 33
ADVAIR DISKUS 168 86 49 37
PANTOPRAZOLE SODIUM 163 108 50 32
FENOFIBRATE 162 55 51 109
DIOVAN 157 125 52 16
OLANZAPINE ODT 156 44 53 196
GENERLAC 152 74 54 140
CLOPIDOGREL 149 111 55 46
ACTOS 146 68 56 89
CARBIDOPA-LEVODOPA 141 79 57 80
LACTULOSE 141 66 57 104
LIDODERM 132 109 59 66
FLUOXETINE HCL 130 110 60 85
ZOLPIDEM TARTRATE 125 91 61 14
NEXIUM 125 67 61 28
ENULOSE 121 57 63 201
LEXAPRO 115 89 64 103
FAMOTIDINE 114 57 65 110
HYDRALAZINE HCL 111 31 66 100
HUMALOG 109 72 67 116
VALPROIC ACID 109 49 67 221
SINGULAIR 105 68 69 82
JANUVIA 104 65 70 49
OXYBUTYNIN CHLORIDE ER 100 96 71 92
DIGOXIN 98 97 72 52
ENOXAPARIN SODIUM 96 71 73 214
FINASTERIDE 95 55 74 76
PLAVIX 94 74 75 61
DOXAZOSIN MESYLATE 92 71 76 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 60 77 118
NOVOLIN R 90 68 78 158
NOVOLOG FLEXPEN 90 90 78 190
FLUTICASONE PROPIONATE 89 67 80 55
TRAVATAN Z 84 76 81 131
ALLOPURINOL 84 65 81 31
OXCARBAZEPINE 83 26 83 199
TOPIRAMATE 81 27 84 162
LOSARTAN POTASSIUM 80 71 85 22
DILTIAZEM 24HR CD 78 66 86 88
LAMOTRIGINE 77 0 87 119
PRAVASTATIN SODIUM 77 72 87 15
PIOGLITAZONE HCL 76 34 R 89 223
CEPHALEXIN 76 62 89 142
LEVOFLOXACIN 76 61 89 96
CARBAMAZEPINE 73 26 92 124
LEVEMIR FLEXPEN 72 72 93 173
BRIMONIDINE TARTRATE 71 62 94 245
EXELON 71 61 94 99
AZITHROMYCIN 69 51 96 39
ALENDRONATE SODIUM 69 56 96 29
CLONIDINE HCL 67 39 98 165
FLUPHENAZINE HCL 67 12 98 269
CIPROFLOXACIN HCL 67 49 98 75
PHENYTOIN SODIUM EXTENDED 65 28 101 149
SPIRONOLACTONE 65 37 101 71
GLUCAGEN 65 32 101 297
LATANOPROST 65 54 101 192
CHLORHEXIDINE GLUCONATE 64 34 105 136
METHOCARBAMOL 63 35 R 106 225
BUPROPION HCL SR 63 38 106 174
SEROQUEL XR 62 22 108 239
DILTIAZEM HCL 61 61 109 242
NUEDEXTA 60 35 110 348
LIPITOR 58 49 111 47
ALBUTEROL SULFATE 58 53 111 155
TORSEMIDE 58 49 111 188
ETODOLAC 58 57 111 285
NITROFURANTOIN MONO-MACRO 57 45 115 180
BENAZEPRIL HCL 55 55 116 112
LISINOPRIL-HYDROCHLOROTHIAZIDE 55 50 116 38
CHLORPROMAZINE HCL 54 0 118 312
MONTELUKAST SODIUM 54 40 118 125
GLIPIZIDE ER 53 28 120 108
CYCLOBENZAPRINE HCL 51 42 R 121 113
PREVACID 51 22 121 383
PROPRANOLOL HCL 50 13 123 167
AMLODIPINE BESYLATE-BENAZEPRIL 50 46 123 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.